GeoWealth Management LLC Sells 2,639 Shares of HCA Healthcare, Inc. (NYSE:HCA)

GeoWealth Management LLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 69.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,145 shares of the company's stock after selling 2,639 shares during the quarter. GeoWealth Management LLC's holdings in HCA Healthcare were worth $344,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Whipplewood Advisors LLC purchased a new stake in HCA Healthcare in the 4th quarter worth approximately $31,000. Tidemark LLC acquired a new stake in HCA Healthcare during the fourth quarter valued at $36,000. Activest Wealth Management increased its position in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after purchasing an additional 125 shares during the last quarter. Pinnacle Bancorp Inc. grew its stake in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after buying an additional 50 shares in the last quarter. Finally, Legacy Investment Solutions LLC raised its position in HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after acquiring an additional 95 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the business's stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.30% of the company's stock.

HCA Healthcare Price Performance

Shares of NYSE:HCA traded down $13.72 during midday trading on Friday, reaching $327.69. 2,803,570 shares of the company's stock were exchanged, compared to its average volume of 1,398,028. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The firm has a market capitalization of $80.68 billion, a PE ratio of 14.92, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48. The company's 50 day simple moving average is $329.82 and its two-hundred day simple moving average is $332.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.77 by $0.68. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. During the same period in the prior year, the firm posted $5.36 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.88%. HCA Healthcare's dividend payout ratio is 13.11%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the stock. Guggenheim initiated coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating on the stock. Robert W. Baird reiterated a "neutral" rating and set a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. KeyCorp reduced their target price on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a report on Tuesday, January 7th. Truist Financial dropped their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Finally, StockNews.com lowered shares of HCA Healthcare from a "buy" rating to a "hold" rating in a research note on Wednesday, April 9th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $381.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.